Quick Answer
LeonaBio, Inc. reported Net Income Loss of -$105.61 million for the year ending 2025.
- LeonaBio, Inc. showed a decrease of -8.9% in Net Income Loss from 2024 to 2025.
- This data is from LeonaBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), LeonaBio, Inc.'s Net Income Loss has declined by 1,946.3%.
- Historical annual values: Fiscal year 2025: -$105.61 million | Fiscal year 2024: -$96.94 million | Fiscal year 2023: -$117.67 million | Fiscal year 2022: -$95.64 million | Fiscal year 2021: -$54.85 million | Fiscal year 2020: -$19.96 million | Fiscal year 2019: -$5.16 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: